When does schizophrenia really begin? - A case report confirming theneurodevelopmental theory of schizophrenia
DOI:
https://doi.org/10.2478/cpp-2021-0003Keywords:
synaptic pruning, neurodevelopment, schizophrenia, geneticAbstract
Introduction: According to the neurodevelopmental theory, schizophrenia is a cognitive-behavioral manifestation of the non-physiological development of the CNS, which was caused by the interaction of genetic and environmental factors during its formation.
Aim, material and methodology: The aim of this article is to present a clinical case in which exposure to numerous adverse environmental factors in the pre and postnatal period could cause the development of schizophrenia in adulthood. The analysis of the clinical case and the medical records of a patient diagnosed with paranoid schizophrenia, suffering from numerous perinatal complications, was performed.
Case report: A woman, 23 years old, unmarried, studying at post-secondary school -archivistics. Currently, psychiatrically hospitalized for the second time. A patient from the first, twin, fraternal pregnancy. The delivery took place by caesarean section, complicated. In the APGAR scale, she scored 4 points in the 1st minute, and 6 points in the 3rd minute. By day 30, the patient had experienced preterm retinopathy, viral infection, salmonella, jaundice and anemia. In the second month of her life, she was treated with surgery due to intestinal obstruction. Psychomotor development was disturbed. At 9 years of age, there was a retinal detachment. Until the end of junior high school, she was educated in a special school for the visually impaired.
Conclusions: The neurodevelopmental theory assumes that the increased risk of developing schizophrenia is associated with unfavorable factors in the developmental period. Identifying the causes underlying the development of the disease is a key step towards prevention, more efficient diagnosis, and improvement of the effectiveness of treatment of patients suffering from this disease.
References
1. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet 2016;388:86-97. https://doi.org/10.1016/S0140¬6736(15)01121-6.
2. Hasan A, Falkai P, Lehmann I, Gaebel W. Schizophrenie. Dtsch Arztebl Int 2020;117:412-9. https://doi.org/10.3238/ arztebl.2020.0412.
3. James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 Diseases and Injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018;392:1789-858. https://doi.org/10.1016/S0140-6736(18)32279-7.
4. Simon GE, Stewart C, Yarborough BJ, Lynch F, Coleman KJ, Beck A, et al. Mortality rates after the first diagnosis of psychotic disorder in adolescents and young adults. JAMA Psychiatry 2018;75:254-60. https://doi.org/10.1001/ jamapsychiatry.2017.4437.
5. Plana-Ripoll O, Pedersen CB, Agerbo E, Holtz Y, Erlangsen A, Canudas-Romo V, et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. Lancet 2019;394:1827-35. https://doi.org/10.1016/S0140-6736(19)32316-5.
6. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, et al. Heritability estimates for psychotic disorders: The Maudsley Twin psychosis series. Arch Gen Psychiatry 1999;56:162-8. https://doi.org/10.1001/archpsyc.56.2.162.
7. Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014;511:421-7. https://doi.org/10.1038/ nature13595.
8. Sullivan PF, Daly MJ, O’Donovan M. Genetic architectures of psychiatric disorders: The emerging picture and its implications. Nat Rev Genet 2012;13:537-51. https://doi.org/10.1038/nrg3240.
9. Balu DT. The NMDA Receptor and Schizophrenia. From Pathophysiology to Treatment. Adv. Pharmacol., vol. 76, Academic Press Inc.; 2016, p. 351-82. https://doi.org/10.1016/bs.apha.2016.01.006.
10. Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: Update 2012. Mol Psychiatry 2012;17:1228-38. https://doi.org/10.1038/mp.2012.23.
11. McGrath J, Brown A, St Clair D. Prevention and schizophrenia -The role of dietary factors. Schizophr Bull 2011;37:272-83. https://doi.org/10.1093/schbul/sbq121.
12. Maxwell AM, Rao RB. Perinatal iron deficiency as an early risk factor for schizophrenia. Nutr Neurosci 2021:1-10. https://doi.org/10.1080/1028415X.2021.1943996.
13. Berridge MJ. Vitamin d deficiency: Infertility and neurodevelopmental diseases (attention deficit hyperactivity disorder, autism, and schizophrenia). Am J Physiol - Cell Physiol 2018;314:C135-51. https://doi.org/10.1152/ajpcell.00188.2017.
14. McCutcheon RA, Reis Marques T, Howes OD. Schizophrenia -An Overview. JAMA Psychiatry 2020;77:201-10. https://doi. org/10.1001/jamapsychiatry.2019.3360.
15. Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, et al. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev 2016;65:185-94. https://doi.org/10.1016/j.neubiorev.2016.03.017.
16. Feinberg I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319-34. https://doi.org/10.1016/0022-3956(82)90038-3.
17. Crow TJ. The two-syndrome concept: Origins and current status. Schizophr Bull 1985;11:471-86. https://doi.org/10.1093/ schbul/11.3.471.
18. Weinberger DR. Implications of Normal Brain Development for the Pathogenesis of Schizophrenia. Arch Gen Psychiatry 1987;44:660-9. https://doi.org/10.1001/archpsyc.1987.01800190080012.
19. Murray RM, Lewis SW, Lecturer L. Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 1987;295:681-2. https://doi.org/10.1136/bmj.295.6600.681.
20. Koshiyama D, Fukunaga M, Okada N, Morita K, Nemoto K, Usui K, et al. White matter microstructural alterations across four major psychiatric disorders: mega-analysis study in 2937 individuals. Mol Psychiatry 2020;25:883-95. https://doi.org/10.1038/s41380-019-0553-7.
21. Wójciak P, Remlinger-Molenda A, Rybakowski J, Psychiatrii K, Um W Poznaniu D. Etapy przebiegu schizofrenii-koncepcja stagingu Stages of the clinical course of schizophrenia-staging concept. Psychiatr Pol 2016;50:717-30. https://doi.org/10.12740/PP/58723.
22. Radhakrishnan R, Skosnik PD, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, et al. In vivo evidence of lower synaptic vesicle density in schizophrenia. Mol Psychiatry 2021:1-9. https://doi.org/10.1038/s41380-021-01184-0.
23. Osimo EF, Beck K, Reis Marques T, Howes OD. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures. Mol Psychiatry 2019;24:549-61. https://doi.org/10.1038/s41380-018-0041-5.
24. Karakuła H, Pelczarska-Jamroga A, Dzikowski M, Próchnicki M, Dzikowska I. Czy schizofrenia rozpoczyna się w życiu płodowym ? Dowody wspierające teorię neurorozwojową. Zdr i Dobrostan Dobrostan i Społeczeństwo 2013;4:111-20.
25. Frese FJ. Neurodevelopment and Schizophreniaedited by Matcheri Keshavan, James Kennedy, and Robin Murray; Cambridge, United Kingdom, Cambridge University Press, 2004, 520 pages, $140. Psychiatr Serv 2006;57. https://doi.org/10.1176/ps.2006.57.6.887.
26. Morimoto K, Nakajima K. Role of the Immune System in the Development of the Central Nervous System. Front Neurosci 2019;13. https://doi.org/10.3389/fnins.2019.00916.
27. Keshavan M, Lizano P, Prasad K. The synaptic pruning hypothesis of schizophrenia: promises and challenges. World Psychiatry 2020;19. https://doi.org/10.1002/wps.20725.
28. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of Schizophrenia, revisited. Schizophr Bull 2009;35. https://doi.org/10.1093/schbul/sbn187.
29. Laurens KR, Luo L, Matheson SL, Carr VJ, Raudino A, Harris F, et al. Common or distinct pathways to psychosis? A systematic review of evidence from prospective studies for developmental risk factors and antecedents of the schizophrenia spectrum disorders and affective psychoses. BMC Psychiatry 2015;15. https://doi.org/10.1186/s12888-015-0562-2.
30. Johnson S, Marlow N. Preterm birth and childhood psychiatric disorders. Pediatr Res 2011;69. https://doi.org/10.1203/ PDR.0b013e318212faa0.
31. Clarke MC, Tanskanen A, Huttunen M, Leon DA, Murray RM, Jones PB, et al. Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: Evidence from a population-based longitudinal study. Am J Psychiatry 2011;168. https://doi.org/10.1176/appi.ajp.2011.11010011.
32. Isohanni M, Jones PB, Moilanen K, Rantakallio P, Veijola J, Oja H, et al. Early developmental milestones in adult schizophrenia and other psychoses. A 31-year follow-up of the Northern Finland 1966 Birth Cohort. Schizophr. Res., vol. 52, 2001. https://doi. org/10.1016/S0920-9964(00)00179-1.
33. Germann M, Brederoo SG, Sommer IEC. Abnormal synaptic pruning during adolescence underlying the development of psychotic disorders. Curr Opin Psychiatry 2021;34. https://doi.org/10.1097/YCO.0000000000000696.
34. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical Abnormalities in the Brains of Monozygotic Twins Discordant for Schizophrenia. N Engl J Med 1990;322. https://doi.org/10.1056/nejm199003223221201.
35. Zaborowski A, Antosik-Biernacka A, Biernacki R, Kłoszewska I, Stefańczyk L. Estimation of brain tissue in schizophrenic patients using magnetization transfer imaging -Preliminary report. Psychiatr Pol 2007;41.
36. Endres D, Matysik M, Feige B, Venhoff N, Schweizer T, Michel M, et al. Diagnosing organic causes of schizophrenia spectrum disorders: Findings from a one-year cohort of the Freiburg diagnostic protocol in psychosis (FDPP). Diagnostics 2020;10. https://doi.org/10.3390/diagnostics10090691.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Authors

This work is licensed under a Creative Commons Attribution 4.0 International License.